Literature DB >> 22113997

The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma.

Summer S Han1, Meredith Yeager, Lee E Moore, Ming-Hui Wei, Ruth Pfeiffer, Ousmane Toure, Mark P Purdue, Mattias Johansson, Ghislaine Scelo, Charles C Chung, Valerie Gaborieau, David Zaridze, Kendra Schwartz, Neonilia Szeszenia-Dabrowska, Faith Davis, Vladimir Bencko, Joanne S Colt, Vladimir Janout, Vsevolod Matveev, Lenka Foretova, Dana Mates, M Navratilova, Paolo Boffetta, Christine D Berg, Robert L Grubb, Victoria L Stevens, Michael J Thun, W Ryan Diver, Susan M Gapstur, Demetrius Albanes, Stephanie J Weinstein, Jarmo Virtamo, Laurie Burdett, Antonin Brisuda, James D McKay, Joseph F Fraumeni, Nilanjan Chatterjee, Philip S Rosenberg, Nathaniel Rothman, Paul Brennan, Wong-Ho Chow, Margaret A Tucker, Stephen J Chanock, Jorge R Toro.   

Abstract

In follow-up of a recent genome-wide association study (GWAS) that identified a locus in chromosome 2p21 associated with risk for renal cell carcinoma (RCC), we conducted a fine mapping analysis of a 120 kb region that includes EPAS1. We genotyped 59 tagged common single-nucleotide polymorphisms (SNPs) in 2278 RCC and 3719 controls of European background and observed a novel signal for rs9679290 [P = 5.75 × 10(-8), per-allele odds ratio (OR) = 1.27, 95% confidence interval (CI): 1.17-1.39]. Imputation of common SNPs surrounding rs9679290 using HapMap 3 and 1000 Genomes data yielded two additional signals, rs4953346 (P = 4.09 × 10(-14)) and rs12617313 (P = 7.48 × 10(-12)), both highly correlated with rs9679290 (r(2) > 0.95), but interestingly not correlated with the two SNPs reported in the GWAS: rs11894252 and rs7579899 (r(2) < 0.1 with rs9679290). Genotype analysis of rs12617313 confirmed an association with RCC risk (P = 1.72 × 10(-9), per-allele OR = 1.28, 95% CI: 1.18-1.39) In conclusion, we report that chromosome 2p21 harbors a complex genetic architecture for common RCC risk variants.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22113997      PMCID: PMC3277315          DOI: 10.1093/hmg/ddr551

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  43 in total

1.  A global map of p53 transcription-factor binding sites in the human genome.

Authors:  Chia-Lin Wei; Qiang Wu; Vinsensius B Vega; Kuo Ping Chiu; Patrick Ng; Tao Zhang; Atif Shahab; How Choong Yong; YuTao Fu; Zhiping Weng; JianJun Liu; Xiao Dong Zhao; Joon-Lin Chew; Yen Ling Lee; Vladimir A Kuznetsov; Wing-Kin Sung; Lance D Miller; Bing Lim; Edison T Liu; Qiang Yu; Huck-Hui Ng; Yijun Ruan
Journal:  Cell       Date:  2006-01-13       Impact factor: 41.582

2.  SequenceLDhot: detecting recombination hotspots.

Authors:  Paul Fearnhead
Journal:  Bioinformatics       Date:  2006-10-23       Impact factor: 6.937

3.  A new multipoint method for genome-wide association studies by imputation of genotypes.

Authors:  Jonathan Marchini; Bryan Howie; Simon Myers; Gil McVean; Peter Donnelly
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

4.  Family history and the risk of kidney cancer: a multicenter case-control study in Central Europe.

Authors:  Rayjean J Hung; Lee Moore; Paolo Boffetta; Bing-Jian Feng; Jorge R Toro; Nathanial Rothman; David Zaridze; Marie Navratilova; Vladimir Bencko; Vladimir Janout; Helena Kollarova; Neonila Szeszenia-Dabrowska; Dana Mates; Wong-Ho Chow; Paul Brennan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-06       Impact factor: 4.254

Review 5.  Current status of genome-wide association studies in cancer.

Authors:  Charles C Chung; Stephen J Chanock
Journal:  Hum Genet       Date:  2011-06-16       Impact factor: 4.132

6.  Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer.

Authors:  M-H Wei; O Toure; G M Glenn; M Pithukpakorn; L Neckers; C Stolle; P Choyke; R Grubb; L Middelton; M L Turner; M M Walther; M J Merino; B Zbar; W M Linehan; J R Toro
Journal:  J Med Genet       Date:  2005-06-03       Impact factor: 6.318

7.  Methods for etiologic and early marker investigations in the PLCO trial.

Authors:  Richard B Hayes; Alice Sigurdson; Lee Moore; Ulrike Peters; Wen-Yi Huang; Paul Pinsky; Douglas Reding; Edward P Gelmann; Nat Rothman; Ruth M Pfeiffer; Robert N Hoover; Christine D Berg
Journal:  Mutat Res       Date:  2005-07-27       Impact factor: 2.433

8.  The consensus coding sequences of human breast and colorectal cancers.

Authors:  Tobias Sjöblom; Siân Jones; Laura D Wood; D Williams Parsons; Jimmy Lin; Thomas D Barber; Diana Mandelker; Rebecca J Leary; Janine Ptak; Natalie Silliman; Steve Szabo; Phillip Buckhaults; Christopher Farrell; Paul Meeh; Sanford D Markowitz; Joseph Willis; Dawn Dawson; James K V Willson; Adi F Gazdar; James Hartigan; Leo Wu; Changsheng Liu; Giovanni Parmigiani; Ben Ho Park; Kurtis E Bachman; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu
Journal:  Science       Date:  2006-09-07       Impact factor: 47.728

9.  SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes.

Authors:  Bernice R Packer; Meredith Yeager; Laura Burdett; Robert Welch; Michael Beerman; Liqun Qi; Hugues Sicotte; Brian Staats; Mekhala Acharya; Andrew Crenshaw; Andrew Eckert; Vinita Puri; Daniela S Gerhard; Stephen J Chanock
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

10.  ORegAnno: an open-access community-driven resource for regulatory annotation.

Authors:  Obi L Griffith; Stephen B Montgomery; Bridget Bernier; Bryan Chu; Katayoon Kasaian; Stein Aerts; Shaun Mahony; Monica C Sleumer; Mikhail Bilenky; Maximilian Haeussler; Malachi Griffith; Steven M Gallo; Belinda Giardine; Bart Hooghe; Peter Van Loo; Enrique Blanco; Amy Ticoll; Stuart Lithwick; Elodie Portales-Casamar; Ian J Donaldson; Gordon Robertson; Claes Wadelius; Pieter De Bleser; Dominique Vlieghe; Marc S Halfon; Wyeth Wasserman; Ross Hardison; Casey M Bergman; Steven J M Jones
Journal:  Nucleic Acids Res       Date:  2007-11-15       Impact factor: 16.971

View more
  20 in total

Review 1.  Renal cell carcinoma deep sequencing: recent developments.

Authors:  Leslie J Farber; Kyle Furge; Bin Tean Teh
Journal:  Curr Oncol Rep       Date:  2012-06       Impact factor: 5.075

Review 2.  Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer.

Authors:  Johannes Schödel; Steffen Grampp; Eamonn R Maher; Holger Moch; Peter J Ratcliffe; Paul Russo; David R Mole
Journal:  Eur Urol       Date:  2015-08-19       Impact factor: 20.096

3.  Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases.

Authors:  Julien Dagher; Solène-Florence Kammerer-Jacquet; Frédéric Dugay; Marion Beaumont; Alexandra Lespagnol; Laurence Cornevin; Grégory Verhoest; Karim Bensalah; Nathalie Rioux-Leclercq; Marc-Antoine Belaud-Rotureau
Journal:  Virchows Arch       Date:  2017-05-10       Impact factor: 4.064

4.  Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study.

Authors:  Fabio A B Schutz; Mark M Pomerantz; Kathryn P Gray; Michael B Atkins; Jonathan E Rosenberg; Michelle S Hirsch; David F McDermott; Megan E Lampron; Gwo-Shu Mary Lee; Sabina Signoretti; Philip W Kantoff; Matthew L Freedman; Toni K Choueiri
Journal:  Lancet Oncol       Date:  2012-12-07       Impact factor: 41.316

5.  Caution in interpreting results from imputation analysis when linkage disequilibrium extends over a large distance: a case study on venous thrombosis.

Authors:  Marine Germain; Noémie Saut; Tiphaine Oudot-Mellakh; Luc Letenneur; Anne-Marie Dupuy; Marion Bertrand; Marie-Christine Alessi; Jean-Charles Lambert; Diana Zelenika; Joseph Emmerich; Laurence Tiret; Francois Cambien; Mark Lathrop; Philippe Amouyel; Pierre-Emmanuel Morange; David-Alexandre Trégouët
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

6.  Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer.

Authors:  Marc Henrion; Matthew Frampton; Ghislaine Scelo; Mark Purdue; Yuanqing Ye; Peter Broderick; Alastair Ritchie; Richard Kaplan; Angela Meade; James McKay; Mattias Johansson; Mark Lathrop; James Larkin; Nathaniel Rothman; Zhaoming Wang; Wong-Ho Chow; Victoria L Stevens; W Ryan Diver; Susan M Gapstur; Demetrius Albanes; Jarmo Virtamo; Xifeng Wu; Paul Brennan; Stephen Chanock; Timothy Eisen; Richard S Houlston
Journal:  Hum Mol Genet       Date:  2012-11-25       Impact factor: 6.150

7.  Common genetic variants in the 9p21 region and their associations with multiple tumours.

Authors:  F Gu; R M Pfeiffer; S Bhattacharjee; S S Han; P R Taylor; S Berndt; H Yang; A J Sigurdson; J Toro; L Mirabello; M H Greene; N D Freedman; C C Abnet; S M Dawsey; N Hu; Y-L Qiao; T Ding; A V Brenner; M Garcia-Closas; R Hayes; L A Brinton; J Lissowska; N Wentzensen; C Kratz; L E Moore; R G Ziegler; W-H Chow; S A Savage; L Burdette; M Yeager; S J Chanock; N Chatterjee; M A Tucker; A M Goldstein; X R Yang
Journal:  Br J Cancer       Date:  2013-01-29       Impact factor: 7.640

8.  A GWAS-identified susceptibility locus on chromosome 11q13.3 and its putative molecular target for prediction of postoperative prognosis of human renal cell carcinoma.

Authors:  Tong Su; Yifang Han; Yongwei Yu; Xiaojie Tan; Xiaopan Li; Jianguo Hou; Yan DU; Jian Shen; Guoping Wang; Liye Ma; Shuang Jiang; Hongwei Zhang; Guangwen Cao
Journal:  Oncol Lett       Date:  2013-06-25       Impact factor: 2.967

9.  Common variation at 1q24.1 (ALDH9A1) is a potential risk factor for renal cancer.

Authors:  Marc Y R Henrion; Mark P Purdue; Ghislaine Scelo; Peter Broderick; Matthew Frampton; Alastair Ritchie; Angela Meade; Peng Li; James McKay; Mattias Johansson; Mark Lathrop; James Larkin; Nathaniel Rothman; Zhaoming Wang; Wong-Ho Chow; Victoria L Stevens; W Ryan Diver; Demetrius Albanes; Jarmo Virtamo; Paul Brennan; Timothy Eisen; Stephen Chanock; Richard S Houlston
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.752

10.  The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer.

Authors:  Andika C Putra; Hidetaka Eguchi; Kian Leong Lee; Yuko Yamane; Ewita Gustine; Takeshi Isobe; Masahiko Nishiyama; Keiko Hiyama; Lorenz Poellinger; Keiji Tanimoto
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.